JeanLudCadetMD(He/Him)

Psychiatry • Baltimore, MD

Addiction, Neuropsychiatry, Psychopharmacology

Chief, Molecular Neuropsychiatry Research Branch, NIH/NIDA/IRP

Join to view full profile

Dr. Cadet is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cadet's full profile

Already have an account?

Office
251 Bayview Blvd
Baltimore, MD 21224
Phone+1 443-740-2656

Fax+1 443-740-2856

Summary

Dr. Jean Cadet is a psychiatrist in Baltimore, MD. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 38 years. He also speaks multiple languages, including French and Creole. He specializes in addiction, neuropsychiatry, and psychopharmacology and is experienced in schizophrenia, brain, central nervous system stimulants, corpus striatum, and dopamine. He has more than 100 publications and over 500 citings.

Education & Training

National Institutes of Health Clinical CenterResidency, Psychiatry, 1984 - 1987
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Neurology, 1982 - 1984
New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 1980 - 1982
Atlantic Health SystemInternship, Transitional Year, 1979 - 1980
Columbia University Vagelos College of Physicians and SurgeonsClass of 1979

Certifications & Licensure

MD State Medical License 1994 - 2022
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

NIH Director's Harvey Bullock, Jr. Award NIH, 2013

Publications & Presentations

PubMed

6 citations
Compulsive drug-taking is associated with habenula-frontal cortex connectivity.
Ying Duan, Pei-Jung Tsai, Betty Jo Salmeron, Yuzheng Hu, Hong Gu
Proceedings of the National Academy of Sciences of the United States of America. 2022-12-13
2 citations
Sex-Dependent Alterations in the mRNA Expression of Enzymes Involved in Dopamine Synthesis and Breakdown After Methamphetamine Self-Administration.
Aaron E Miller, Atul P Daiwile, Jean Lud Cadet
Neurotoxicity Research. 2022-10-01
10 citations
Biochemical Neuroadaptations in the Rat Striatal Dopaminergic System after Prolonged Exposure to Methamphetamine Self-Administration.
Subramaniam Jayanthi, Bruce Ladenheim, Patricia Sullivan, Michael T McCoy, Irina N Krasnova
International Journal of Molecular Sciences. 2022-09-03

Press Mentions

My Quest for SadnessOctober 13th, 2020

Grant Support

Protective Effects Of DA Antagonists V METH Induced Toxicity In RatsNational Institute On Drug Abuse2009–2011
Neurotoxicity In The Adult RAT Following Chronic Exposure To MethamphetamineNational Institute On Drug Abuse2009–2011
Methamphetamine Administration Causes Death Of Dopaminergic Neurons In The MouseNational Institute On Drug Abuse2009–2011
CDNA Array Analysis Of Cu/Zn SOD TG Mice Treated With Neurotoxic Doses Of AMPHNational Institute On Drug Abuse2009–2011
Neurological Assessments Of Marijuana Users.National Institute On Drug Abuse2009
Serial Analysis Of Gene Expression In The RAT Striatum Following MethamphetamineNational Institute On Drug Abuse2007–2008
Neurological Assessments Of Marijuana Users.National Institute On Drug Abuse2007–2008
Methamphetamine Administration Causes Death Of Dopaminergic Neurons In The MouseNational Institute On Drug Abuse2007–2008
METH Causes Alterations In The MAP Kinase-Related Pathways In The Brains Of MiceNational Institute On Drug Abuse2007–2008
CDNA Array Analysis Of Cu/Zn SOD TG Mice Treated With Neurotoxic Doses Of AMPHNational Institute On Drug Abuse2007–2008
Dose-Related Neurocognitive Effects Of Marijuana UseNational Institute On Drug Abuse2003–2007
CDNA Array Analysis Of Cu/Zn SOD TG Mice Treated With NENational Institute On Drug Abuse2003–2006
CDNA Array Analysis Of Cu/Zn SOD TG Mice Treated W/ AMPHNational Institute On Drug Abuse2005
Analysis Of Ecstasy (Mdma)-Induced TranscriptionNational Institute On Drug Abuse2005
Analysis Of Ecstasy (Mdma)-Induced Transcriptional RespoNational Institute On Drug Abuse2003–2004
Methamphetamine Causes Widespread Apoptosis In The MouseNational Institute On Drug Abuse2002
Methamphetamine Causes Differential Regulation In BCL-2National Institute On Drug Abuse2002
Molecular Neurotoxicological Models Of ParkinsonismNational Institute On Drug Abuse2001–2002
Methamphetamine Causes Widespread ApoptosisNational Institute On Drug Abuse2001
Methamphetamine Causes Differential Regulation Of BCL2National Institute On Drug Abuse2001
Gender Differences In The EEG Of Abstinent Cocaine Abusers.National Institute On Drug Abuse2000
Direct Interactions Of Methamphetamine With The Nucleus.National Institute On Drug Abuse2000
Caffeine Withdrawal Increases Blood Flow And Alters EEG ActivityNational Institute On Drug Abuse2000
Cocaine And Limbic Prefrontal Cortical FunctionNational Center For Research Resources2000
Overexpression Of Human Cu/Zn SOD In TG Mice Attenuates Oxidative Stress By MDMANational Institute On Drug Abuse1998–1999
Neurovascular Deficits In Cocaine AbusersNational Institute On Drug Abuse1998–1999
Dose-Related Neurobehavioral Effects Of Chronic Cocaine UseNational Institute On Drug Abuse1998–1999
Toxicity Of Amphetamine AnalogsNational Institute On Drug Abuse1996–1997
Neuropsychiatric Evaluation Of Drug Using HIV Positive/Negative IndividualsNational Institute On Drug Abuse1996–1997
Mechanisms Of Cell Death Caused By MethamphetamineNational Institute On Drug Abuse1996–1997
Role Of P53 In Methamphetamine Induced Neurotoxicity In MiceNational Institute On Drug Abuse1996
The Neuropsychiatric Evaluation Of HIV Positive Drug Using IndividualsNational Institute On Drug Abuse1995
Free Radicals On Opioid Receptor FunctionNational Institute On Drug Abuse1995